College of Food Science and Engineering, Northwest A&F University, Yangling, 712100, China.
Laboratory of Quality & Safety Risk Assessment for Agro-products (Yangling), Ministry of Agriculture, Yangling, 712100, China.
Food Funct. 2023 Oct 30;14(21):9920-9935. doi: 10.1039/d3fo01796f.
The aim of this study was to evaluate the intervention effect of the potential probiotic YG-4 isolated from Tibetan kefir grains on alcoholic liver disease (ALD). Eight-week-old male C57BL/6J mice were fed with a Lieber-DeCarli (LDC) diet containing ethanol with a progressively increasing concentration from 1% to 4% (vol/vol) to establish an ALD mouse model. Our results suggested that treatment improved ALD, as demonstrated by the reduction of serum ALT and AST levels and the suppression of TLR4/NF-κB-mediated inflammatory response in the liver. administration significantly elevated antioxidant activities of SOD, CAT and GSH-Px, and reduced the MDA level in mice. supplementation repaired the gut barrier by increasing tight junction proteins and the number of goblet cells in the colon of ALD mice. In addition, treatment with restored alcohol-induced gut dysbiosis. Specifically, administration depleted the abundance of , _ and , while increased that of , and in mice. Our findings open new possibilities for application in ALD treatment.
本研究旨在评估从藏式克菲尔粒中分离出的潜在益生菌 YG-4 对酒精性肝病 (ALD) 的干预效果。将 8 周龄雄性 C57BL/6J 小鼠用含有乙醇的 Lieber-DeCarli (LDC) 饮食喂养,乙醇浓度从 1%逐渐增加到 4%(体积/体积),以建立 ALD 小鼠模型。我们的结果表明,治疗改善了 ALD,表现为血清 ALT 和 AST 水平降低,以及肝脏 TLR4/NF-κB 介导的炎症反应受到抑制。YG-4 给药显著提高了 SOD、CAT 和 GSH-Px 的抗氧化活性,并降低了小鼠的 MDA 水平。YG-4 补充通过增加紧密连接蛋白和结肠杯状细胞的数量修复了酒精性肝病小鼠的肠道屏障。此外,YG-4 治疗恢复了酒精引起的肠道菌群失调。具体来说,YG-4 给药减少了 、 和 _ 的丰度,而增加了 、 和 _ 的丰度。我们的研究结果为 YG-4 在 ALD 治疗中的应用开辟了新的可能性。